Table 1.
Clinical courses for each patient
| Hospitalization number | Presentation | Active inflammation (yes/no/unknown) | Methylprednisolone dose | Concomitant therapies | Disease-free interval | |
|---|---|---|---|---|---|---|
| Patient 1 | 1 | VT storm | Yes | 500 mg × 3 | IV amiodarone Mexiletine 300 mg TID Prednisone 60 mg daily Adalimumab |
15 months |
| 2 | PVC/NSVT | Yes | 1000 mg × 3 | Methotrexate 12.5 mg weekly Mexiletine 300 mg TID Adalimumab |
1 month | |
| 3 | PVC/NSVT | Unknown | 1000 mg × 3 | Methotrexate Mexiletine 300 mg TID Adalimumab |
>2 months | |
| Patient 2 | 1 | VT storm | Yes | 500 mg × 1 | IV amiodarone | 6 months |
| 2 | VT storm | Yes | 1000 mg × 1 500 mg × 1 |
IV amiodarone Methotrexate 15 mg weekly |
1 month | |
| Patient 3 | 1 | VT storm | Yes | 500 mg × 3 | IV amiodarone | >16 months |
IV = intravenous; NSVT = nonsustained ventricular tachycardia; PVC = premature ventricular complexes; TID = 3 times per day; VT = ventricular tachycardia.